Cassava (SAVA) rose 10.40%
Cassava Sciences Inc (NASDAQ: SAVA) shares rose 10.40%, or $11.33 per share, to close Thursday at $120.30. After opening the day at $109.96, shares of Cassava fluctuated between $126.52 and $108.33. 6,776,580…
From the Equity Insider archive. This article dates from Aug 13, 2021 and is preserved as first published.
Cassava Sciences Inc (NASDAQ: SAVA) shares rose 10.40%, or $11.33 per share, to close Thursday at $120.30. After opening the day at $109.96, shares of Cassava fluctuated between $126.52 and $108.33. 6,776,580 shares traded hands an increase from their 30 day average of 6,753,446. Thursday’s activity brought Cassava’s market cap to $4,813,767,809.
Cassava is headquartered in Austin, Texas..
About Cassava Sciences Inc
Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease.
